A case of central diabetes insipidus associated with cardiac dysfunction.

Nobumasa Ohara,Masanori Kaneko, Tatsuya Suwabe, Tasuku Yoshie, Hiroyuki Kuwano,Katsuya Ebe,Toshio Fujita,Koichi Fuse,Kenzo Kaneko,Kyuzi Kamoi

Clinical case reports（2016）

引用 1|浏览14

暂无评分

摘要

Central diabetes insipidus (CDI) results from a deficiency of arginine vasopressin (AVP) secretion. It is treated by replacement therapy with the synthetic AVP analogue desmopressin. To prevent heart failure in patients with CDI accompanied by cardiac dysfunction, controlling sodium and water intake is essential, using the minimum effective dose of desmopressin.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要